Driving research of Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME / CFS),
Post Treatment Lyme Disease Syndrome (PTLDS), Fibromyalgia and Post COVID .

Mitochondrial Function Test

TECHNOLOGY VALUE

Demonstrates a significant difference between ME / CFS patients and healthy controls.

LEAD INVESTIGATORS
  • Julie Wilhelmy

  • Ronald W. Davis, PhD

UPDATES AND POTENTIAL

Coming soon…

 

TECHNOLOGY DESCRIPTION

Julie Wilhelmy, SGTC

Developed by Julie Wilhelmy in collaboration with Ronald W. Davis, PhD, at Stanford University.

The Seahorse instrument measures oxygen during energy production processes that occur in the mitochondria. A protocol using the Seahorse has revealed a significant difference between activated T-cells of ME / CFS patients and healthy controls.

The instrument is commercially available, which will allow other laboratories to easily reproduce the results.

 

 

Mitochondrial Function Test

TECHNOLOGY  DESCRIPTION

Julie Wilhelmy, SGTC

Developed by Julie Wilhelmy, PhD, in collaboration with Ronald W. Davis, PhD, at Stanford University.

The Seahorse instrument measures oxygen during energy production processes that occur in the mitochondria. A protocol using the Seahorse has revealed a significant difference between activated T-cells of ME/CFS patients and healthy controls.

The instrument is commercially available, which will allow other laboratories to easily reproduce the results.